Cambridge Healthtech Institute’s Eleventh Annual
Molecular Diagnostics
The Industry Leader’s Networking Event
Part of the 21st Annual Molecular Medicine Tri-Conference
February 10-12, 2014 | Moscone North Convention Center | San Francisco, CA
Medical practice is becoming dependent on molecular tests for therapy selection and treatment decisions, forcing a paradigm shift to enable personalized medicine. This reality will translate to great improvements in the speed, efficiency, accuracy and overall cost of medicine and allow for accountable care organizations (ACO). Cambridge Healthtech Institute's Molecular Diagnostics is known for bringing together industry leaders and providing a platform for major announcements. This year's meeting will address tactical challenges in the process of implementing personalized medicine throughout an organization and personalizing patient care including: how to pay for it, how to translate the results of tests to physicians and patients, and how to integrate it throughout an organization. Setting up systems for handling high volumes of multi-source data will be reviewed by key players in the industry. Practical guidelines for all aspects of personalized medicine and companion diagnostics will be considered and explored.
Who should attend: Vice Presidents, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields of Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.
Topics will include, but are not limited to:
- Newest FDA guidance for companion diagnostics, LDTs and NGS
- Novel treatment strategies using molecular diagnostics
- Fully integrating personalized medicine into health systems
- Starting up a next-gen lab
- Commercialization strategies for assay launch
- Review of newest companion diagnostic products on the market
- Molecular testing for infectious diseases
- Support for physician decision making
- Changing landscape of mobile health and impact on personalized medicine
- Integrating genomic services into clinical care
- Overcoming obstacles to developing companion diagnostics
- Impact of accountable care organizations (ACO)
- Review latest diagnostic approaches using cell-free DNA
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for submission is July 19, 2013.
All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, contact:
Christina Lingham
Executive Producer, Conferences
Cambridge Healthtech Institute
T: (+1) 781-972-5464
E: clingham@healthtech.com
For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com
Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com